FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090561 [Registered on: 09/07/2025] Trial Registered Prospectively
Last Modified On: 08/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Non-randomized, Placebo Controlled Trial 
Public Title of Study   Exploring Brahmi Ghrita Nasya for Cognitive Impairment Following ECT in Depression Patients 
Scientific Title of Study   A Randomized Controlled Study of Brahmi Ghrita Nasya (BGN) for the Amelioration of Cognitive Impairment Following Electroconvulsive Therapy in Patients with Depression. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vandana PV 
Designation  Junior Resident 
Affiliation  NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES BANGLORE 
Address  Department of Integrative Medicine National Institute of Mental Health and Neuro Sciences Banglore Karnataka
National Institute of Mental Health and Neuro Sciences Banglore Karnataka
Bangalore
KARNATAKA
560029
India 
Phone  09562573623  
Fax    
Email  vandanathamban@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kishore Kumar R 
Designation  Professor HOD 
Affiliation  NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES BANGLORE 
Address  Department of Integrative Medicine, National Institute of Mental Health and Neurosciences Bengaluru Karnataka

Bangalore
KARNATAKA
560029
India 
Phone  9845829174  
Fax    
Email  ayurkishore@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vandana PV 
Designation  Junior Resident 
Affiliation  NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES BANGLORE 
Address  Department of Integrative Medicine National Institute of Mental Health and Neurosciences Bengaluru Karnataka

Bangalore
KARNATAKA
560029
India 
Phone  09562573623  
Fax    
Email  vandanathamban@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Mental Health and Neurosciences Bengaluru Karnataka 
 
Primary Sponsor  
Name  Dr Vandana PV 
Address  Department of Integrative Medicine National Institute of Mental Health and Neurosciences Bengaluru Karnataka 
Type of Sponsor  Other [STUDENT] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vandana PV  National Institute of Mental Health and Neurosciences Bengaluru Karnataka  Department of Integrative Medicine National Institute of Mental Health and Neurosciences Bengaluru Karnataka
Bangalore
KARNATAKA 
9562573623

vandanathamban@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Human Ethics Committee For Research in AYUSH and Integrative Medicine  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G||Mental Health. Ayurveda Condition: UNMADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-nasyam/ nastam, नस्यम्/ नस्तम् (Procedure Reference: Ashtanga Hridaya, Procedure details: Purvakarma-Abhyanga (massage) should be done on scalp, forehead,face and neck for 3 to 5 minutes by medicated oil . Swedana may be given for elimination of Doshas and liquification of Doshas. Pradhana karma-Patient should lie down in supine position with ease on Nasya table. The therapist should raise the tip of the patient’s nose with his left thumb and with the right hand 5-6 drops of medicated ghee (brahmi ghrita)should be droppedin both the nostrils alternately . Pashat karma-After administration of medication through Nasal passage patient should lie supine (Uttana) for about 2 minute time interval & ask him to count numbers upto 100. After an administration of Nasya feets, shoulders, palms and ears should be massaged. Patient should spit out the medicine which have come into the oropharynx. )
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Diagnosed patients with depression who are indicated for bifrontal electroconvulsive therapy (ECT) and are undergoing a minimum of three ECT sessions
Patients who are cooperative for baseline cognitive assessment
Age between 18 and 65 years 
 
ExclusionCriteria 
Details  Uncontrolled diabetes mellitus or hypertension
Age below 18 years or above 65 years
Pregnant women
Presence of any severe physical illness
Intellectual disability disorder
Patients undergoing bitemporal ECT or unilateral ECT
Pre-existing cognitive disorder
Neurological illnesses
Substance use disorder (excluding nicotine dependence)
Vitamin B12 deficiency or thyroid deficiency disorders 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Visual and autobiographical memories were tested using subsets of the B4ECT ReCoDe.  Base line, after3 rd ECT, after 6th ECT, after last ECT 
 
Secondary Outcome  
Outcome  TimePoints 
Verbal memory and working memory were assessed using the Rey Auditory Verbal Learning Test (RAVLT), Digit Span, and Spatial Span tests.
Verbal fluency was evaluated using the Controlled Oral Word Association Test (COWAT).
Adverse effects were measured by UKU scale. 
Baseline, after 3rd ECT, after 6th ECT, after last ECT. 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   24/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Depression is the most common psychiatric disorder in world population and  ECT is considered as most effective treatment for severe , psychotic, or treatment resistant depression .Studies suggested that ECT is associated with acute deficits in cognitive domains .There is a paucity of literature to suggest efficacy of intervention on cognitive impairment following ECT. Study found that bacopa monnieri can improve higher order cognitive process and panchakarma therapy like nasya is useful in the treatment of dementia. Hence the study aims to evaluate efficacy of brahmi ghrita nasya in ameliorating ECT induced cognitive impairment in depression. 
Close